• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡纳万病:生物化学与分子研究

Canavan disease: biochemical and molecular studies.

作者信息

Matalon R, Kaul R, Michals K

机构信息

Research Institute Miami Children's Hospital, FL 33155.

出版信息

J Inherit Metab Dis. 1993;16(4):744-52. doi: 10.1007/BF00711906.

DOI:10.1007/BF00711906
PMID:8412017
Abstract

Deficiency of the enzyme aspartoacylase and the accumulation of N-acetylaspartic acid lead to a severe leukodystrophy and spongy degeneration of the brain, Canavan disease (McKusick 271900). Since our discovery in 1988 of the defect in Canavan disease, 144 patients with Canavan disease have been diagnosed in our laboratory. Most of these children are of Ashkenazi Jewish extraction. The level of enzyme activity can be used for carrier testing. Prenatal diagnosis has been difficult using the enzyme assay owing to the low activity of aspartoacylase in cultured chorionic villus samples or amniocytes. The determination of N-acetylaspartic acid in the amniotic fluid is another parameter for diagnosis; however, the levels may not always be elevated. Bovine and human aspartoacylase have been purified in our laboratory. Bovine and human cDNA and genomic clones have been isolated and six exons have been localized. This information is being used for the study of Canavan disease at the molecular level.

摘要

天冬氨酸酰基转移酶缺乏以及N - 乙酰天冬氨酸的积累会导致严重的脑白质营养不良和脑海绵状变性,即卡纳万病(麦库西克编号271900)。自1988年我们发现卡纳万病的缺陷以来,我们实验室已诊断出144例卡纳万病患者。这些儿童大多来自德系犹太人。酶活性水平可用于携带者检测。由于培养的绒毛膜绒毛样本或羊水中天冬氨酸酰基转移酶活性较低,使用酶测定法进行产前诊断一直很困难。羊水N - 乙酰天冬氨酸的测定是另一个诊断参数;然而,其水平并非总是升高。我们实验室已纯化了牛和人的天冬氨酸酰基转移酶。已分离出牛和人的cDNA及基因组克隆,并确定了六个外显子的位置。这些信息正用于卡纳万病的分子水平研究。

相似文献

1
Canavan disease: biochemical and molecular studies.卡纳万病:生物化学与分子研究
J Inherit Metab Dis. 1993;16(4):744-52. doi: 10.1007/BF00711906.
2
Canavan disease: diagnosis and molecular analysis.卡纳万病:诊断与分子分析
Genet Test. 1997;1(1):21-5. doi: 10.1089/gte.1997.1.21.
3
Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings.脑海绵状变性,卡纳万病:生化及分子学发现
Front Biosci. 2000 Mar 1;5:D307-11. doi: 10.2741/matalon.
4
Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.人天冬氨酸酰基转移酶cDNA的克隆及Canavan病中的一个常见错义突变
Nat Genet. 1993 Oct;5(2):118-23. doi: 10.1038/ng1093-118.
5
Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis.通过DNA分析对卡纳万病(天冬氨酸酰基转移酶缺乏症)进行产前检测。
J Inherit Metab Dis. 1994;17(6):664-6. doi: 10.1007/BF00712008.
6
Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.Canavan病患者的天冬氨酸酰基转移酶缺乏症和N-乙酰天冬氨酸尿症。
Am J Med Genet. 1988 Feb;29(2):463-71. doi: 10.1002/ajmg.1320290234.
7
Canavan disease: from spongy degeneration to molecular analysis.卡纳万病:从海绵状变性到分子分析
J Pediatr. 1995 Oct;127(4):511-7. doi: 10.1016/s0022-3476(95)70105-2.
8
Biochemistry and molecular biology of Canavan disease.卡纳万病的生物化学与分子生物学
Neurochem Res. 1999 Apr;24(4):507-13. doi: 10.1023/a:1022531829100.
9
Molecular basis of Canavan's disease: from human to mouse.卡纳万病的分子基础:从人类到小鼠
J Child Neurol. 2003 Sep;18(9):604-10. doi: 10.1177/08830738030180090601.
10
Canavan disease: a monogenic trait with complex genomic interaction.卡纳万病:一种具有复杂基因组相互作用的单基因性状。
Mol Genet Metab. 2003 Sep-Oct;80(1-2):74-80. doi: 10.1016/j.ymgme.2003.08.015.

引用本文的文献

1
Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.天冬氨酸酰基转移酶的细胞和分子机制及其在卡纳万病中的作用。
Cell Biosci. 2024 Apr 6;14(1):45. doi: 10.1186/s13578-024-01224-6.
2
Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme.天门冬氨酸酶基因突变致病性的比较计算评估。
Metab Brain Dis. 2017 Dec;32(6):2105-2118. doi: 10.1007/s11011-017-0090-5. Epub 2017 Sep 6.
3
Structural modeling of p.V31F variant in the aspartoacylase gene.天冬氨酸酰基转移酶基因中p.V31F变异体的结构建模

本文引用的文献

1
Studies on the role of N-acetylaspartic acid in mammalian brain.N-乙酰天门冬氨酸在哺乳动物大脑中的作用研究。
J Gen Physiol. 1959 Nov;43(2):323-33. doi: 10.1085/jgp.43.2.323.
2
SPONGY DEGENERATION OF WHITE MATTER: CANAVAN'S SCLEROSIS.
Neurology. 1965 Feb;15:165-71. doi: 10.1212/wnl.15.2.165.
3
SPONGY DEGENERATION OF THE NERVOUS SYSTEM. A REPORT OF FOUR CASES WITH A REVIEW OF THE LITERATURE.
Neurology. 1965 Mar;15:207-22. doi: 10.1212/wnl.15.3.207.
4
Metab Brain Dis. 2016 Jun;31(3):723-6. doi: 10.1007/s11011-016-9796-z. Epub 2016 Jan 21.
4
Making the White Matter Matters: Progress in Understanding Canavan's Disease and Therapeutic Interventions Through Eight Decades.让白质病变至关重要:八十年来对卡纳万病的认识进展与治疗干预
JIMD Rep. 2015;19:11-22. doi: 10.1007/8904_2014_356. Epub 2015 Jan 21.
5
A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice.在 P20 时,单次静脉注射 rAAV 即可在 Canavan 小鼠中实现有效且持续的中枢神经系统基因治疗。
Mol Ther. 2013 Dec;21(12):2136-47. doi: 10.1038/mt.2013.138. Epub 2013 Jul 2.
6
Relationship between enzyme properties and disease progression in Canavan disease.脑腱黄瘤病中酶特性与疾病进展的关系。
J Inherit Metab Dis. 2013 Jan;36(1):1-6. doi: 10.1007/s10545-012-9520-z. Epub 2012 Aug 1.
7
Mutational analysis of aspartoacylase: implications for Canavan disease.天冬氨酸酰基转移酶的突变分析:对卡纳万病的意义。
Brain Res. 2007 May 7;1148:1-14. doi: 10.1016/j.brainres.2007.02.069. Epub 2007 Mar 3.
8
Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.非犹太裔卡纳万病患者中天冬氨酸酰基转移酶基因新突变的鉴定与特征分析。
J Inherit Metab Dis. 2002 Nov;25(7):557-70. doi: 10.1023/a:1022091223498.
9
Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.卡纳万病。对导致所观察到的临床症状发展的代谢性病变性质的分析。
J Mol Neurosci. 1997 Oct;9(2):109-25. doi: 10.1007/BF02736855.
10
Canavan disease: mutations among Jewish and non-Jewish patients.卡纳万病:犹太患者和非犹太患者中的突变情况。
Am J Hum Genet. 1994 Jul;55(1):34-41.
SPONGY DEGENERATION OF THE CENTRAL NERVOUS SYSTEM IN INFANCY.
婴儿期中枢神经系统海绵状变性
Neurology. 1964 Nov;14:981-1001. doi: 10.1212/wnl.14.11.981.
5
N-Acetyl-L-aspartic acid in brain.大脑中的N-乙酰-L-天冬氨酸。
J Biol Chem. 1956 Mar;219(1):257-64.
6
Developmental changes of N-acetyl-L-aspartic acid, N-acetyl-alpha-aspartylglutamic acid and beta-citryl-L-glutamic acid in different brain regions and spinal cords of rat and guinea pig.
J Neurochem. 1981 Oct;37(4):1064-7. doi: 10.1111/j.1471-4159.1981.tb04500.x.
7
Computed tomography in the diagnosis of Canavan's disease.
Ann Neurol. 1981 Jul;10(1):57-60. doi: 10.1002/ana.410100112.
8
A gas chromatographic method for the determination of N-acetyl-L-aspartic acid, N-acetyl-alpha-aspartylglutamic acid and beta-citryl-L-glutamic acid and their distributions in the brain and other organs of various species of animals.
J Neurochem. 1981 Mar;36(3):804-10. doi: 10.1111/j.1471-4159.1981.tb01665.x.
9
Spongy degeneration of the brain in Israel: a retrospective study.
Clin Genet. 1983 Jan;23(1):23-9. doi: 10.1111/j.1399-0004.1983.tb00432.x.
10
Amino acid sequence of the N alpha-terminal 201 residues of human erythrocyte membrane band 3.人红细胞膜带3的Nα-末端201个残基的氨基酸序列。
J Biol Chem. 1983 Jul 10;258(13):7981-90.